EARLY BIRD DISCOUNT! Register by May 7, 2014 to receive 20% off your registration!
Register 3 for the price of 2 with the coupon code rcdvb!

 Overview | Speakers | Agenda | Poster Submissions | Venue | Sponsors
Please select which speaker list you would like to view
5th Cancer Targets and Therapeutics 
3rd Oncology Partnering & Deal-Making 
Top of Page

5th Cancer Targets and Therapeutics 
DISTINGUISHED SPEAKERS
Philip M. Arlen
President & CEO; Attending Physician, Medical Oncology Branch GU Oncology Section Center for Cancer Research
Precision Biologics; National Cancer Institute
 
Julie Bailis
Principal Scientist, Oncology
Amgen
Ho Man Chan
Investigator III
Novartis Institutes for BioMedical Research, Inc.
Robert Copeland
Exectuive Vice President & Chief Scientific Officer
Epizyme
Keith Dionne
President & Chief Executive Officer
Constellation Pharmaceuticals
Marion Dorsch
Vice President, Biology
Agios Pharmaceutical
Alan Epstein
Professor of Pathology
USC, Keck School of Medicine
Denise Faustman
Associate Professor of Medicine
Harvard Medical School
Director
MGH Immunobiology Laboratory
Christopher Alexander French
Associate Professor, Pathology
Brigham And Women's Hospital
Keith Knutson
Affiliate Associate Professor of Immunology, Consultant (Supplemental), Mayo Clinic Rochester; Director, Cancer Vaccines and Immune Therapies Program, Principal Investigator, Full Member, Vaccine & Gene Therapy Institute of Florida
Hella Kohlhof
Manager Translational Pharmacology
4SC AG
Paul Moore
Vice President, Cell Biology & Immunology
MacroGenics
Peter Park
Vice President, Biology
Mersana Therapeutics
Jun Qi
Senior Research Scientist
Dana-Farbor Cancer Institute, Harvard Medical School
Venkateshwar Reddy
Head, Bio-Innovation France, Global BioTherapeutics

Sanofi R&D
Angus Sinclair
Scientific Director
Amgen
Susan Slovin
Medical Oncologist
Memorial Sloan Kettering
Edward van der Horst 
Director, Preclinical Development
Igenica Biotherapeutics
Domagoj Vucic
Senior Scientist, Early Discovery Biology
Genentech
Please check back for updates!
Top of Page

3rd Oncology Partnering & Deal-Making 
KEYNOTE SPEAKERS & PANELISTS
Varavani Dwarki
Vice President & Worldwide Head
Alliance Management, Oncology and NCI Liaison
Sanofi
Philippe Lopes-Fernandes
Senior Vice President
Global Licensing, Business Development & Alliance Management
Merck Serono
 
Anne Altmeyer
Vice President
Business Development & Licensing, Oncology
Novartis
Paul Juniewicz
Head, Oncology Business Opportunities
Strategic Portfolio and Management Group, Oncology
(former Vice President, External Innovation Department )
Sanofi
 
FEATURED SPEAKERS & PANELISTS
Nick D’Aleandro
Senior Director, Business Development
Johnson & Johnson
John Gustofson
Senior Director, Ventures & Early Stage Collaborations
AbbVie
 
John Herrmann
Senior Director, Global External R&D, Oncology
Eli Lilly
Shakti Narayan
Senior Director, Transactions
Johnson & Johnson Innovation Center
 
DISTINGUISHED SPEAKERS & PANELISTS
Martin Buckland
Chief Business Officer
Astex Pharmaceuticals
Casi DeYoung
Chief Business Officer
Mirna Therapeutics
Scott Jordan
President,
S. Jordan Associates;
Consultant,
CrowdFundConnect
Jeff Karan
Senior Partner
Woodside Capital Partners
Daniel Koerwer
Senior Vice President, Business Development and Commercial
BIND Therapeutics
Winston Kung
Chief Business Officer
Celgene
Kyle Kuvalanka
Chief Business Officer
Blueprint Medicines
Luc Marengere
Managing Partner
TVM Life Science Management Inc.
Chrysa Mineo
Senior Vice President, Corporate Development
Receptos
Edwind Moses
Chief Executive Officer
Ablynx
Catherine-Anne Pickering
Head, Oncology Licensing & Global Business Development 
Merck Serono
Dennis Purcell
Senior Managing Partner
Aisling Capital
Debanjan Ray
VP, Business Development & Alliance Management
Cytomx
Jigar Raythatha
Chief Business Officer
Jounce Therapeutics
Eric Risser
Vice President, Business Development
MacroGenics
Reginald Seeto
Head of Partnering and Strategy
MedImmune
Bimal R. Shah
Vice President, Corporate & Business Development
Spectrum Pharmaceuticals
Jay Shepard
Executive Partner
Sofinnova Ventures
Hamza Suria
President & Chief Executive Officer
AnaptysBio
Charles Theuer
President and Chief Executive Officer
Tracon Pharma
Please check back for updates!
Top of Page
Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!